Pharmaceutical Industry

Is the
current model fit for purpose?

These are symptoms of a decline of the pre-digital era model of medicinal product development. Our pharmaceutical industry members are those who are committed to moderninsing their product development to create safer and more effective medicinal products. 

Modernisation of the pharmaceutical industry requires a coresponding moderninsation of the way in which medicinal products are brought on to the market and the design of clinical trials. The Avicenna Alliance is working to promote modelling and simulation as a means of addressing the high cost of research and the uptake of in silico methods.

Avicenna Alliance news

In silico method mentioned in JRC report on alternatives to animal testing

On 7 February, the European Union Reference Laboratory for Alternatives to Animal Testing (EURL ECVAM) - which is an...

find out more ›

Artificial Intelligence and clinical research: which issues remain?

This issue is discussed in the new article written under the direction of Vincent Diebolt, Director of the French Clinical Research...

find out more ›

FEops  joins Avicenna Alliance

As further evidence of the Alliance’s growing momentum, Avicenna Alliance is happy to announce the newest addition to our list of members: FEops.

find out more ›

Show all activites